SCHEMBL1633245

SCHEMBL1633245

CC(C)NCCCNc1ccc(-c2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 4/20 0.46
CA2 P00918 9/20 0.42
CDK2 P24941 3/20 0.42
CDK1 P06493 2/20 0.42
CDK4 P11802 2/20 0.42
KDR P35968 2/20 0.42
CDK7 P50613 2/20 0.42
CDK9 P50750 2/20 0.42
CCNT1 O60563 1/20 0.42
CCND1 P24385 1/20 0.42
CCNH P51946 1/20 0.42
CCNB1 P14635 1/20 0.42
CCNE1 P24864 1/20 0.42
CA1 P00915 6/20 0.42
CA9 Q16790 6/20 0.42
IKBKB O14920 3/20 0.42
CA4 P22748 2/20 0.41
CA12 O43570 1/20 0.40
JUN P05412 1/20 0.40
NTRK1 P04629 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498354 0.86 MAPK10 (0.49) MAPK10CA2CDK2CDK1CDK4
SCHEMBL1633475 0.86 MAPK10 (0.53) MAPK10CA2CDK2CDK1CDK4
SCHEMBL1634634 0.85 MAPK10 (0.48) MAPK10CA2CDK2CDK1CDK4
SCHEMBL1634792 0.85 MAPK10 (0.43) MAPK10CA2CDK2CDK1CDK9
SCHEMBL1633211 0.84 MAPK10 (0.48) MAPK10CA2CDK2CDK1CDK4
SCHEMBL1632848 0.84 CA2 (0.56) MAPK10CA2CDK2CDK1CDK4
SCHEMBL1633149 0.83 CA1 (0.48) MAPK10CA2CDK2CDK1CDK9
SCHEMBL1633121 0.79 MAPK10 (0.52) MAPK10CA2CA1CA9CA12
SCHEMBL1632787 0.78 JAK2 (0.45) MAPK10CA2CDK2CDK1CDK9
SCHEMBL1631911 0.78 MAPK10 (0.55) MAPK10CA2CDK2CDK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed